US 9353112
Synthesis of polycyclic alkaloids
granted A61PA61P3/00
Quick answer
US patent 9353112 (Synthesis of polycyclic alkaloids) held by Rigel Pharmaceuticals, Inc. expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61P, A61P3/00